Page results
-
UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.
-
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.
-
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Following the successful premiere at Everyman Cinema, Muswell Hill, SICKLE, the groundbreaking documentary on sickle cell disorder, continued its impactful journey with a screening at Ritzy Picture House in Brixton on Thursday 24 October. Held in celebration of Black History Month, the event aimed to raise awareness and educate both healthcare professionals and the public about the realities of living with sickle cell disorder.
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
Professor Ed Wild, NHNN consultant neurologist and associate director of UCL Huntington’s Disease Centre has contributed an afterword to a new memoir by journalist Charlotte Raven, called Patient 1, Forgetting and Finding Myself.
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
File results
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0146 - Total bed management contract with Medstrom
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0188 - Payments to suppliers
-
FOI/2023/0202 - Nitrous oxide/ Entonox personal sampling for staff
-
FOI/2023/0203 - Maintenance contract(s) for flexible endoscope inventory
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0211 - Services available to older residents
-
FOI/2023/0212 - Training provided to clinical staff for use of medical devices